Testing effectiveness (Phase 2)Study completedNCT00064025
What this trial is testing
Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus
Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation+5 more
Gynecologic Oncology Group 75